Chemotherapy doesn’t just kill cancer cells. It also affects the microbes in the digestive tract. Researchers at UC San Francisco have discovered that some gut bacteria can reduce the side effects of ...

Accurate classification of breast cancer receptor status can help guide treatment decisions, making more patients eligible for HER2 targeted therapies.

Adding inavolisib to palbociclib and fulvestrant improved overall survival for people with previously treated PIK3CA-mutated HR-positive, HER2-negative advanced breast cancer.

Based on findings of a new study, American Cancer Society researchers stress the need for survivors to incorporate physical activity into their daily routine ...

University of Colorado Cancer Center member Al Barqawi, MD, talks about the latest developments in the disease. May 28, 2025 • By Greg Glasgow at the University of Colorado Cancer Center ...